Most Recent
Cipla attacks patent extension for Novo Nordisk weight loss drug
Intellectual Property 2024-10-30 11:01 pm By Andy Sidler

Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

AstraZeneca sues to put the brakes on Brilinta generic
Intellectual Property 2024-10-29 11:33 pm By Andy Sidler

AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

New battle in Lexapro patent war between Lundbeck, Sandoz
Appeals 2024-10-18 11:17 pm By Christine Caulfield

Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Westpac fights bid to ‘get around’ limitation defence in flex commissions class action
Class Actions 2024-08-21 11:11 pm By Sam Matthews

Banks targeted in long-running class actions over flexible commission schemes for car dealers are resisting the plaintiffs’ bid to amend their pleadings to “get around” the defence that certain claims are time-barred.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fanatics wins timeout amid appeal of loss to AFL merchandise maker
Appeals 2024-08-15 11:55 pm By Cindy Cameronne

A judge has granted a limited stay of an injunction against US sports merchandise Fanatics after AFL merchandise maker FanFirm won its case alleging the US company knew about its ‘Fanatics’ trade marks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

AFL merch maker wins trade mark suit against US company Fanatics
Intellectual Property 2024-07-18 10:02 pm By Sam Matthews

AFL merchandise maker FanFirm has won a trade mark case against US sports merchandise giant Fanatics, with a judge finding it knew about the Australian company’s ‘Fanatics’ trade marks when it chose its corporate name.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Origin Energy fires off cross-claim in trade mark fight
Intellectual Property 2024-07-03 11:53 pm By Sam Matthews

Energy retailer Origin Energy has hit back at a trade mark infringement suit filed by internet provider Origin Net, arguing that its mark should be revoked and accusing Origin Net of misleading and deceptive conduct. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Neurim’s claim for additional damages survives in Circadin patent case
Intellectual Property 2024-06-03 11:48 pm By Sam Matthews

A judge has upheld Neurim Pharmaceutical’s claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company’s failure to comply with an earlier ruling.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

7-Eleven defeats Seven Network’s opposition to ‘7-Select’ trade mark
Intellectual Property 2024-05-03 11:51 pm By Andy Sidler

Convenience chain 7-Eleven has defeated Seven Network’s challenge to its bid to trade mark ‘7-Select’ for a new brand of products targeting younger shoppers, with an IP Australia delegate finding consumer confusion was not likely.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

After 7 years of litigation, patent for blockbuster sleep drug Circadin found valid
Intellectual Property 2024-04-18 11:21 pm By Sam Matthews

After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?